Back to top

Image: Bigstock

Altria (MO) Reports Q3 Earnings: What Key Metrics Have to Say

Read MoreHide Full Article

Altria (MO - Free Report) reported $5.44 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 3.6%. EPS of $1.52 for the same period compares to $1.45 a year ago.

The reported revenue represents a surprise of +2.61% over the Zacks Consensus Estimate of $5.3 billion. With the consensus EPS estimate being $1.51, the EPS surprise was +0.66%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Altria performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenues net of excise taxes- Oral Tobacco Products: $667 million versus $694.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.3% change.
  • Revenues net of excise taxes- Smokeable Products: $4.76 billion versus $4.62 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
  • Operating Companies Income- Reported OCI- Oral Tobacco Products: $434 million versus $467.09 million estimated by two analysts on average.
  • Operating Companies Income- Adjusted OCI- Smokeable Products: $3.07 billion versus the two-analyst average estimate of $3.02 billion.
  • Operating Companies Income- Reported OCI- All Other: $-88 million compared to the $-75 million average estimate based on two analysts.

View all Key Company Metrics for Altria here>>>

Shares of Altria have returned +8.4% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Published in